Picture of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS logo

ONCSM.E Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Cashflow Statement

0.000.00%
tr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.9518.771.7-20.8-79.8
Depreciation
Deferred Taxes
Non-Cash Items5.115.595.22-2.7238.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital5.97-10.3-3325.1-40.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities16.619.451.745-57.3
Capital Expenditures-14.7-16.3-13-26-31.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1260.078-24.8-1.059.88
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-14.8-16.2-37.8-27.1-21.7
Financing Cash Flow Items-4.37-4.43-2.31-1.4786.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.09-1.63-16.6-14.3118
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.941.55-2.653.6339.3